Involvement of FGFR4 in Pulmonary Fibrosis Pathophysiology

被引：0
|
作者：
Ghanem, M. [1 ]
Justet, A. [1 ]
Jaillet, M. [1 ]
Hachem, M. [1 ]
Boghanim, T. [1 ]
Vadel, A. [1 ]
Mailleux, A. [1 ]
Crestani, B. [2 ]
机构：
[1] INSERM, U1152, Paris, France
[2] Hop Bichat Claude Bernard, Serv Pneumol, Paris, France
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 203卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4220
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The Role FGFR4 in Pancreatic Endocrine Tumors
    Serra, S.
    Ezzat, S.
    Chetty, R.
    Asa, S. L.
    MODERN PATHOLOGY, 2009, 22 : 120A - 120A
  • [22] FGFR4 Arg388 allele correlates with tumour thickness and FGFR4 protein expression with survival of melanoma patients
    Streit, S.
    Mestel, D. S.
    Schmidt, M.
    Ullrich, A.
    Berking, C.
    BRITISH JOURNAL OF CANCER, 2006, 94 (12) : 1879 - 1886
  • [23] Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4
    Kristen C Hart
    Scott C Robertson
    Martha Y Kanemitsu
    April N Meyer
    John A Tynan
    Daniel J Donoghue
    Oncogene, 2000, 19 : 3309 - 3320
  • [24] Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4
    Hart, KC
    Robertson, SC
    Kanemitsu, MY
    Meyer, AN
    Tynan, JA
    Donoghue, DJ
    ONCOGENE, 2000, 19 (29) : 3309 - 3320
  • [25] Loss of FGFR4 promotes the malignant phenotype of PDAC
    Sabrina D’Agosto
    Francesco Pezzini
    Lisa Veghini
    Pietro Delfino
    Claudia Fiorini
    Gael D. Temgue Tane
    Anais Del Curatolo
    Caterina Vicentini
    Giorgia Ferrari
    Davide Pasini
    Silvia Andreani
    Francesca Lupo
    Elena Fiorini
    Giulia Lorenzon
    Rita T. Lawlor
    Borislav Rusev
    Antonia Malinova
    Claudio Luchini
    Michele Milella
    Elisabetta Sereni
    Antonio Pea
    Claudio Bassi
    Peter Bailey
    Aldo Scarpa
    Emilio Bria
    Vincenzo Corbo
    Oncogene, 2022, 41 : 4371 - 4384
  • [26] FGFR4 Y367C: Contributes to a constitutively active FGFR4 and tumor aggressiveness in breast cancer cell line
    Foo, P.
    Ho, H. K.
    Streit, S.
    Ruhe, J. E.
    Hart, S.
    Ullrich, A.
    EJC SUPPLEMENTS, 2008, 6 (12): : 114 - 114
  • [27] An FGFR4 polymorphism is implicated in the progression of neuroendocrine tumors
    Serra, S.
    Zheng, L.
    Chetty, R.
    Ezzat, S.
    Asa, S. L.
    VIRCHOWS ARCHIV, 2009, 455 : 41 - 41
  • [28] Loss of FGFR4 promotes the malignant phenotype of PDAC
    D'Agosto, Sabrina
    Pezzini, Francesco
    Veghini, Lisa
    Delfino, Pietro
    Fiorini, Claudia
    Tane, Gael D. Temgue
    Del Curatolo, Anais
    Vicentini, Caterina
    Ferrari, Giorgia
    Pasini, Davide
    Andreani, Silvia
    Lupo, Francesca
    Fiorini, Elena
    Lorenzon, Giulia
    Lawlor, Rita T.
    Rusev, Borislav
    Malinova, Antonia
    Luchini, Claudio
    Milella, Michele
    Sereni, Elisabetta
    Pea, Antonio
    Bassi, Claudio
    Bailey, Peter
    Scarpa, Aldo
    Bria, Emilio
    Corbo, Vincenzo
    ONCOGENE, 2022, 41 (38) : 4371 - 4384
  • [29] FGFR4 Pathway Mutations in Embryonal Type of Rhabdomyosarcoma
    Sato, Aiko
    Seki, Masafumi
    Shiraishi, Yuichi
    Chiba, Kenichi
    Tanaka, Hiroko
    Okita, Hajime
    Miyano, Satoru
    Ogawa, Seishi
    Hosoi, Hajime
    Takita, Junko
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S28 - S28
  • [30] FGFR3 and FGFR4 contribute to resistance in the therapy of colorectal cancer in vitro
    Erdem, Z. N.
    Heinzle, C.
    Sonvilla, G.
    Grasl-Kraupp, B.
    Holzmann, K.
    Grusch, M.
    Berger, W.
    Marian, B.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S552 - S552
12345